Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine and pentoxifylline for leishmaniasis in the elderly
NCT06040489Phase 3Recruiting
- Sponsor
- University of Brasília
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miltefosine, pentoxifylline in cutaneous leishmaniasis (CL), Mucocutaneous leishmaniasis (MCL), sponsored by University of Brasília. Started Jun 2022; status: recruiting.
02
Drugs
miltefosinepentoxifylline
03
Conditions
cutaneous leishmaniasis (CL)Mucocutaneous leishmaniasis (MCL)
Beyond the preview
Go deeper on NCT06040489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040489.